Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Rising Healthcare Costs Supporting Growth of the US Generics Industry

May 19, 2011
Share |
 
As per our new research report “Booming US Generic Drug Market”, high healthcare costs in the country has raised a lot concerns in the Government, and the regulatory authorities are shifting their support towards generics industry to help curb the costs. Apart from this, the generics industry is also receiving a boost from the several patent expirations lined up for blockbuster drugs during the next few years. On the back of this, many generic companies have already lined up the generic versions of these blockbuster drugs to be introduced in the market as soon as the patent is lifted. Along with these factors, revival of the country’s economy and increasing per capita income of the people will also help the generics market to grow at a CAGR of 10% during 2010-2013.
 
Through in depth research and prudent analysis of the industry, we have identified that, the new government reforms making health insurance compulsory will also support the generics industry. The hospital sector will also come forth as a top consumer of these generics, especially to treat people with less fortunate financial conditions. The report also covers prominent factors, which will act as a catalyst for the industry’s current and future growth outlook.
 
Our report also includes a pragmatic study of the potential of generic drugs in various therapeutics segments of the pharmaceutical industry, which will give a clear idea about the type of products available in the market. Moreover, overview of the regulatory environment regarding pharmaceutical industry in the country will help in the identification of the supportive factors for the generics market. Besides, the report also discusses several industry bottlenecks that are blocking the growth of generics industry in the country.
 
The report, “Booming US Generic Drug Market”, covers various growth-supporting factors, such as macroeconomic environment, healthcare reform plans, and its impact and other growth supporting factors. The report thoroughly examines the current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. Forecast in this research has been prepared considering the possible post-recession impact on the industry.

For more information visit: http://www.rncos.com/Report/IM589.htm

Related Press Releases:
» Neurological Drug Market to Grow at a CAGR of around 10% during 2011-2014
» Stupendous Growth Observed in Global Genetic Testing Market
» US Generics Market Poised for Stupendous Growth
» Antipsychotics to Drive the US Generics Market
» Generic Medicines Dominating Prescription Market in the UK
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports